All myeloproliferative neoplasms may lead to elevated uric acid levels and gout as a result of increased cellular breakdown.
[amboss.com]
Not meeting the WHO criteria for BCR-ABL11 CML, PV, ET, myelodysplastic syndrome s, or other myeloid neoplasms 3.
[seer.cancer.gov]
Clinical manifestations depend on the type of blood cell affected and may include anemia, pallor, splenomegaly, hypermetabolic state, petechiae, ecchymosis, bleeding, lymphadenopathy
[orpha.net]